• Return to Headlines

Neurocrine Biosc Has Returned 23.7% Since SmarTrend Recommendation (NBIX)

By Shiri Gupta

SmarTrend identified an Uptrend for Neurocrine Biosc (NASDAQ:NBIX) on April 30th, 2018 at $81.68. In approximately 1 month, Neurocrine Biosc has returned 23.74% as of today's recent price of $101.07.

Neurocrine Biosc share prices have moved between a 52-week high of $102.83 and a 52-week low of $41.76 and are now trading 142% above that low price at $101.07 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has advanced 1.3%.

Neurocrine Biosciences, Inc. is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. The Company is developing therapeutic interventions for anxiety, depression, alzheimer's disease, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity, and diabetes.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Neurocrine Biosc shares.

Log in and add Neurocrine Biosc (NBIX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights neurocrine biosc

Ticker(s): NBIX